Product information

Sandostatine Long Acting Repeatable 20 mg
20 mg + 2 ml
octreotide
1395060
5.06 / 10
Locked

Product properties

83150-76-9
H01CB02
Novartis Pharma
Powder and solvent for suspension for injection
€598.46
BE191737
07612797280447
M42
Public
191737-01

Pharmacist Assessment

Structurally fluctuating availability

This product has chronically fluctuating availability (current 5.06/10, historical 🔒/10). Be prepared for possible supply issues and consider keeping an alternative in stock.

No available alternative found in the system. Consult the physician for a therapeutic alternative.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 12 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Available again Active
- present
Temporarily unavailable
-

Delay in production

In principle, sufficient stock in circulation (short term)

Composition

4 ingredients

Substance Type Strength CAS
Active ingredient
22.4 mg
79517-01-4
Excipient
15 mg
Excipient
81.9 mg
Excipient
12.5 mg

Additional information

Availability statistics

Available again
18 days
4
0
23/06/2026